Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.34 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.34 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.31 |
| ▸ | KCNA5 | P22460 | 3/20 | 0.31 |
| ▸ | CNR1 | P21554 | 1/20 | 0.31 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.31 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.31 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.31 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2335178 | 0.92 | CYP2A6 (0.38) | CYP2A6KDM4ETSHRSMN1; SMN2LMNA | |
| SCHEMBL2525463 | 0.89 | SMN1; SMN2 (0.37) | TSHRSMN1; SMN2LMNAL3MBTL1ADRB2 | |
| SCHEMBL2335611 | 0.87 | TSHR (0.41) | TSHRSMN1; SMN2LMNAL3MBTL1ADRB2 | |
| SCHEMBL2339629 | 0.85 | TSHR (0.44) | CYP2A6KDM4ETSHRSMN1; SMN2LMNA | |
| SCHEMBL2331512 | 0.84 | ANO1 (0.38) | TSHRSMN1; SMN2LMNAL3MBTL1ADRB2 | |
| SCHEMBL2331569 | 0.84 | KCNA5 (0.41) | TSHRSMN1; SMN2LMNAL3MBTL1ADRB2 | |
| SCHEMBL2335937 | 0.84 | ADRB2 (0.39) | TSHRSMN1; SMN2LMNAL3MBTL1ADRB2 | |
| SCHEMBL2338152 | 0.83 | SMN1; SMN2 (0.40) | TSHRSMN1; SMN2LMNAL3MBTL1ADRB2 | |
| SCHEMBL2334066 | 0.83 | SMN1; SMN2 (0.40) | TSHRSMN1; SMN2LMNAL3MBTL1ADRB2 | |
| SCHEMBL2334388 | 0.83 | CYP2A6 (0.38) | CYP2A6KDM4ETSHRSMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2358201-A2 | THIOPHENE, FURAN AND PYRROLE DERIVATIVES FOR USE AS PLANT GROWTH REGULATORS | Syngenta Participations AG (CH) | 2011-08-24 | — | — | EP | claimed |
| US-20100273650-A1 | Fungicidal Mixtures Comprising a Substituted 3-Hydroxymethylpyridine and a Further Fungicidal Compound | BASF SE (DE) | 2010-10-28 | — | — | US | claimed |
| EP-2230909-A2 | FUNGICIDAL MIXTURES COMPRISING A SUBSTITUTED 3-HYDROXYMETHYLPYRIDINE AND A FURTHER FUNGICIDAL COMPOUND | BASF SE (DE) | 2010-09-29 | — | — | EP | claimed |
| WO-2010069880-A2 | THIOPHENE, FURAN AND PYRROLE DERIVATIVES FOR USE AS PLANT GROWTH REGULATORS | SYNGENTA PARTICIPATIONS AG (CH) | 2010-06-24 | — | — | WO | claimed |
| WO-2009063074-A2 | FUNGICIDAL MIXTURES I | BASF SE (DE) | 2009-05-22 | — | — | WO | claimed |
| US-20070244162-A1 | SUBSTITUTED AROMATIC HETEROCYCLIC COMPOUNDS AS FUNGICIDES | SYNGENTA LIMITED (GB) | 2007-10-18 | — | — | US | claimed |
| US-20110251069-A1 | ISOXAZOLE DERIVATIVES FOR USE AS PLANT GROWTH REGULATORS | SYNGENTA CROP PROTECTION LLC (US) | 2011-10-13 | — | — | US | disclosed |
| US-20110251069-A1 | ISOXAZOLE DERIVATIVES FOR USE AS PLANT GROWTH REGULATORS | SYNGENTA CROP PROTECTION LLC (US) | 2011-10-13 | — | — | US | disclosed |
| US-20110251069-A1 | ISOXAZOLE DERIVATIVES FOR USE AS PLANT GROWTH REGULATORS | SYNGENTA CROP PROTECTION LLC (US) | 2011-10-13 | — | — | US | disclosed |
| EP-2358201-A2 | THIOPHENE, FURAN AND PYRROLE DERIVATIVES FOR USE AS PLANT GROWTH REGULATORS | Syngenta Participations AG (CH) | 2011-08-24 | — | — | EP | disclosed |
| EP-2230909-A2 | FUNGICIDAL MIXTURES COMPRISING A SUBSTITUTED 3-HYDROXYMETHYLPYRIDINE AND A FURTHER FUNGICIDAL COMPOUND | BASF SE (DE) | 2010-09-29 | — | — | EP | disclosed |
| WO-2010069880-A2 | THIOPHENE, FURAN AND PYRROLE DERIVATIVES FOR USE AS PLANT GROWTH REGULATORS | SYNGENTA PARTICIPATIONS AG (CH) | 2010-06-24 | — | — | WO | disclosed |
| WO-2009063074-A2 | FUNGICIDAL MIXTURES I | BASF SE (DE) | 2009-05-22 | — | — | WO | disclosed |
| US-20070244162-A1 | SUBSTITUTED AROMATIC HETEROCYCLIC COMPOUNDS AS FUNGICIDES | SYNGENTA LIMITED (GB) | 2007-10-18 | — | — | US | disclosed |
| US-20070244162-A1 | SUBSTITUTED AROMATIC HETEROCYCLIC COMPOUNDS AS FUNGICIDES | SYNGENTA LIMITED (GB) | 2007-10-18 | — | — | US | disclosed |
| US-20070244162-A1 | SUBSTITUTED AROMATIC HETEROCYCLIC COMPOUNDS AS FUNGICIDES | SYNGENTA LIMITED (GB) | 2007-10-18 | — | — | US | disclosed |
| WO-2007075487-A2 | SUBSTITUTED AROMATIC HETEROCYCLIC COMPOUNDS AS FUNGICIDES | SYNGENTA LIMITED (GB) | 2007-07-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070244162-A1 | SUBSTITUTED AROMATIC HETEROCYCLIC COMPOUNDS AS FUNGICIDES | NOX5, CYP3A5, API5 | CYP2A6 340/4885KDM4E 691/4885TSHR 2380/4885 |
| US-20100273650-A1 | Fungicidal Mixtures Comprising a Substituted 3-Hydroxymethylpyridine and a Further Fungicidal Compound | CBR3, NOX3, CBR1 | CYP2A6 76/4885KDM4E 1518/4885TSHR 954/4885 |
| US-20110251069-A1 | ISOXAZOLE DERIVATIVES FOR USE AS PLANT GROWTH REGULATORS | FKBP5, FKBP2, FKBP1B | CYP2A6 2016/4885KDM4E 818/4885TSHR 556/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.